https://doi.org/10.1002/jps.22550
C
Christopher R. Gibson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
2.5K
Citations
22
h-index
37
i10-index
Christopher R. Gibson is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Drug Transport and Resistance Mechanisms & Computational Drug Discovery Methods. The author has an h-index of 22, co-authored 63 publications.
ORCID: 0000-0002-1719-8629Papers by this author
worksPHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach
2011 · Journal of Pharmaceutical Sciences · 170 citations
Drug Interaction PBPK Modeling: Review of the Literature Exposes the Need for Increased Verification of Model Inputs and Outputs as Part of Credibility Assessment
2025 · Clinical and Translational Science · 6 citations
https://doi.org/10.1111/cts.70299
Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate
2020 · Pharmaceutical Research · 5 citations
https://doi.org/10.1007/s11095-020-02914-9
Large-Scale Compartmental Model-Based Study of Preclinical Pharmacokinetic Data and Its Impact on Compound Triaging in Drug Discovery
2025 · Molecular Pharmaceutics · 2 citations
https://doi.org/10.1021/acs.molpharmaceut.4c00813
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat